Takeda 3025

Our clinic is looking for children and teens with moderate to severe Ulcerative Colitis (UC) or Crohn’s Disease (CD) to take part in a clinical study. The study is being conducted to evaluate the safety and effectiveness of an investigational drug to manage the symptoms of Ulcerative Colitis or Crohn’s Disease in children.

Your child or teen may qualify if they:

  • Are 2 years to 17 years old
  • Have been diagnosed with moderate-to-severe UC or CD
  • Currently experience change in frequency of bowel movements, fatigue, abdominal pain or other symptoms that may indicate a flare in their disease
  • UC/CD symptoms are not well controlled by current treatments
  • Meet additional study criteria Study staff will determine eligibility based on additional study criteria.

The investigational study drug and all study-related care are provided at no cost.

Location: Northeast Minneapolis Clinic

Physician Investigator: Dr. Arumugam

Study Coordinator: Naomi Mugarura

 

 

RISE study

We are looking for children and teens who are diagnosed with Crohn’s disease (CD) to take part in a research study for an investigational drug. The study will evaluate the safety and effectiveness of an investigational drug to manage CD symptoms in children.

  • Children and teens between the ages of 2 to <18 years of age may be eligible to participate.
  • Participants will receive study drug and all related study procedures that are required at no cost.
  • Reimbursement for travel may be available.
  • To see if the is right for your child, please contact us.

Location: MNGI Digestive Health, Northeast Minneapolis Clinic

Physician Investigator: Ramalingam Arumugam, M.D.

Study Coordinator: Roxie Strehlo

 

 

AbbVie M14-671

We are looking for children and teens who have been diagnosed with Crohn’s Disease (CD) to take part in a research study for an investigational medication. The study will evaluate the safety and effectiveness of an investigational oral drug to manage CD symptoms in children.

Your child or teen may qualify if they:

  • Are 2 to <18 years of age.
  • Weigh at least 22 lbs.
  • Have been diagnosed with Crohn’s Disease.

Participants will receive the study medication and all related study procedures that are required at no cost. To see if this study is right for your child, please contact us.

Location: MNGI Digestive Health, Northeast Minneapolis Clinic

Physician Investigator: Ramalingam Arumugam, M.D.

Study Coordinator: Naomi Mugarura

ATTENTION: This form is for information only and does not guarantee participation in any study. This form is also not meant for transmitting medical, prescription or appointment information or to initiate direct communications with our health care providers. Those inquiries should be sent through the Patient Portal or you can contact us at (612) 871-1145. Web form submissions are monitored Monday through Friday during regular business hours. In the event of a medical emergency, please dial 911.

CAPTCHA
5 + 11 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.